have been sicker than control patients. Patients with schizophrenia are at higher risk for medical illnesses than people in the general population. The risk of atherosclerosis and cardiac death in these patients is markedly higher and parallels the severity of the disease. 6 Last but not least, one should mention the role of the treating physician in the unwanted occurrence of abnormal QTc prolongation and SCD, mostly resulting from torsade de pointes (TdP). There is no question that the most effective way of preventing complications due to drug-induced QTc prolongation is to avoid the use of these drugs. However, there are many QTcprolonging drugs which have certain therapeutic advantages which the physician usually does not want to miss. In these cases, a systematic approach seems advisable. First of all, the physician prescribing such a drug must be familiar with the problem of drug-induced TdP. Moreover, the physician should also know that the risk for abnormal QTc prolongation and TdP varies between patients; although some patients may have a high propensity to the development of drug-associated TdP, the risk may be low in others. Risk factors for the occurrence of the arrhythmia have been identified (e.g. female gender, bradycardia, and hypokalaemia). Thus, although the role of regulatory authorities in pharmacology is crucial, we should not forget the role of the prescribing physician. Drug-induced sudden cardiac death: reply
Wilhelm Haverkamp
We would like to thank Dr Haverkamp and colleagues for their interest in our work. In the first analysis, we focused on the association between antipsychotics and sudden cardiac death. We agree that patients with schizophrenia are at higher risk for medical illnesses than people in the general population. Therefore, we adjusted for indication and showed that the risk of sudden cardiac death was also increased in patients receiving antipsychotics for other indications than schizophrenia. 1 In addition, we had in our study complete access to the full medical records of all participants, including hospitalizations and specialists information. Therefore, we were able to gather complete information on known risk factors for sudden cardiac death and other co-variates. These risk factors and co-variates were included in our analysis [cerebrovascular and cardiovascular ischaemia (history of myocardial infarction, stroke, and angina pectoris), heart failure, hypertension, diabetes mellitus, arrhythmia, hypercholesterolaemia, smoking, and alcohol abuse] and we feel that we have accounted for many of the factors that might increase the risk of sudden cardiac death. In the second study, we investigated the association between all QTcprolonging drugs from a website and sudden cardiac death to study their clinical relevance. Indeed, the contribution of antipsychotics to this problem was relatively substantial and therefore we referred to this earlier study.
We fully agree with Dr Haverkamp and colleagues that the role of the treating physician is crucial in weighing risk benefit of the drugs prescribed. It is crucial that the treating physician is aware of the possible adverse effects of the treatment and we do hope that our study will enable the physicians to choose optimal therapy for their patients. 
S.M.J.M. Straus

Complete myocardial revascularization: between myth and reality
We read with great interest the article by Zimarino et al. 1 focusing on the complex issue of complete vs. incomplete myocardial revascularization in patients submitted to percutaneous or surgical coronary intervention. We believe that the authors correctly pointed out some caveats of available literature in this regard, resulting mainly from the lack of prospective randomized investigation specifically designed to address this controversial topic. However, the authors failed to acknowledge that the benefit of early intervention when compared with the conservative approach in patients with non-ST segment elevation acute coronary syndrome (NSTEACS) known to be at medium or highrisk for future cardiovascular events, as mainly supported by the results of FRISC II, 2 TACTICS-TIMI 18, 3 and RITA 3 4 trials, was obtained following a complete revascularization strategy, either accomplished through Letters to the Editorpercutaneous or surgical approach, depending on coronary anatomy. In fact, in all three trials supporting the benefit of invasive strategy vs. conservative strategy, independently from the possibility to identify and treat the culprit lesion, an aggressive revascularization to all coronary segments presenting with significant (.70% at visual estimation) stenosis was protocol-mandated. The relatively high number of patients who received coronary artery bypass grafting (CABG) at 1 year, among those in whom myocardial revascularization was found to be feasible and clinically indicated in the invasive arm of these trials (50% in FRISC II, 34% in TACTICS-TIMI 18, and 37% in RITA 3), may also indirectly confirm that a multivessel intervention was often accomplished. This is clearly more in line with a complete revascularization strategy rather than a culprit lesion-oriented approach. Yet, it is noteworthy that in the FRISC II and TACTICS trials, despite the fact that the majority of the surgical procedures were performed in patients with left main or multivessel disease early after infarction (,7 days), CABG was associated with a low-risk of mortality (%2%). 2, 3 Thus, whether early intervention is undertaken in patients with NSTEACS, as currently recommended by ACC/AHA 5 and ESC guidelines, 6 any attempt to pursuit a complete revascularization should be thoroughly carried out, well beyond and independently from the possibility to identify and treat the culprit lesion. Indeed, complete revascularization in this setting might be beneficial due to the deleterious progression of unstable plaques otherwise left untreated in the non-culprit vessel(s). 7 The failure of current guidelines to address the issue of adequacy of coronary revascularization in patients affected by NSTEACS should be regarded as a potential source of incomprehension, and a position statement in this regard in the upcoming guidelines updates seems to be highly warranted.
